Kardigan

Develops cardiovascular drug candidates for genetic dilated cardiomyopathy, aortic valve stenosis and acute severe hypertension

+ Add to sales board

Recent signals

What changed at Kardigan in the last 6 months, newest first. Each line links to its public source.

  • 5 Nov 2026 Leadership hire · Hiring Senior Director, Development Operations & Biometrics, Strategy &… (Princeton) job-boards.greenhouse.io
  • 5 Nov 2026 Leadership hire · Hiring Associate Director / Director, Data & AI Solution Development (Princeton) job-boards.greenhouse.io
  • 2 Nov 2026 New team · First manufacturing role: Senior Director, Head of GxP Compliance job-boards.greenhouse.io
  • 2 Nov 2026 Leadership hire · Hiring Associate Director, Statistical Programming (South San Francisco) job-boards.greenhouse.io

Get signals like these for the companies you sell to →

About Kardigan

Kardigan is a heart health company developing targeted cardiovascular drug candidates. It has three late-stage clinical programs, for genetic dilated cardiomyopathy, calcific aortic valve stenosis and acute severe hypertension, and aims to develop several targeted treatments in parallel.

Its Cardiac Intelligence approach combines real-world patient data and AI insights with cardiovascular expertise to inform drug discovery and development. The company is supported by Prolaio, its subsidiary, which provides an AI and real-world data platform used to inform clinical trial design. The stated focus is patients with cardiovascular diseases and their families.

Kardigan has offices in Princeton, New Jersey; South San Francisco, California; and Evanston, Illinois. Its co-founder Tassos Gianakakos is Chief Executive Officer and Chair. Open positions cover clinical development, regulatory, medical affairs, accounting, clinical operations and investor relations.

Product: Clinical-stage cardiovascular drug candidates for genetic dilated cardiomyopathy, calcific aortic valve stenosis and acute severe hypertension.

Jobs at Kardigan

No open positions in Europe right now.

Open roles at Kardigan in the Americas (27)

United States 27. From Kardigan's careers page or applicant tracking system; each role links to the employer.

Newest 12 of 27.

Leadership

More biotech & pharma companies

  • Madrigalpharma

    Develops MASH medicines for patients and healthcare systems in the United States and Europe
    United StatesBiotech & pharma7 open jobs
    New on Evolc
  • Modernatx

    MRNA-based vaccines and medicines for patients, with research in Cambridge and manufacturing in Norwood, MA
    United StatesBiotech & pharma100 open jobs
    New on EvolcRemote-friendly
  • Msd

    Biopharmaceutical maker of medicines, vaccines and animal health products for patients, doctors and veterinarians
    United StatesBiotech & pharmaFounded 1891222 open jobs
    New on EvolcRemote-friendly
  • Neurocrine

    Develops medicines for patients with neurological, psychiatric, endocrine and immunological disorders
    United StatesBiotech & pharma8 open jobs
    New on EvolcRemote-friendly
  • Olema Oncology

    Clinical-stage biopharmaceutical developing novel therapies for patients with metastatic breast cancer
    United StatesBiotech & pharma
  • Oxfordbiotherapeutics

    Develops antibody-based cancer therapies and target-discovery services for oncology partners and patients
    Oxford, United StatesBiotech & pharmaFounded 20031 open job
    Remote-friendlySalary transparent

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Gravity FormsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.